- Home
- TAK vs CCI Comparison
TAK vs CCI Comparison
Compare TAK & CCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- CCI
- Stock Information
- Founded
- TAK 1781
- CCI 1994
- Country
- TAK Japan
- CCI United States
- Employees
- TAK N/A
- CCI N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- CCI Real Estate Investment Trusts
- Sector
- TAK Health Care
- CCI Real Estate
- Exchange
- TAK Nasdaq
- CCI Nasdaq
- Market Cap
- TAK 42.2B
- CCI 41.7B
- IPO Year
- TAK N/A
- CCI 1998
- Fundamental
- Price
- TAK $15.04
- CCI $95.09
- Analyst Decision
- TAK
- CCI Buy
- Analyst Count
- TAK 0
- CCI 18
- Target Price
- TAK N/A
- CCI $112.88
- AVG Volume (30 Days)
- TAK 1.5M
- CCI 2.8M
- Earning Date
- TAK 05-08-2025
- CCI 03-13-2025
- Dividend Yield
- TAK 3.39%
- CCI 6.58%
- EPS Growth
- TAK 15.39
- CCI N/A
- EPS
- TAK 0.83
- CCI 2.82
- Revenue
- TAK $29,124,927,177.00
- CCI $6,593,000,000.00
- Revenue This Year
- TAK $8.53
- CCI N/A
- Revenue Next Year
- TAK N/A
- CCI N/A
- P/E Ratio
- TAK $36.00
- CCI $33.74
- Revenue Growth
- TAK 9.83
- CCI N/A
- 52 Week Low
- TAK $12.58
- CCI $84.20
- 52 Week High
- TAK $15.22
- CCI $120.92
- Technical
- Relative Strength Index (RSI)
- TAK 70.24
- CCI 55.22
- Support Level
- TAK $14.83
- CCI $92.90
- Resistance Level
- TAK $15.22
- CCI $101.06
- Average True Range (ATR)
- TAK 0.17
- CCI 2.54
- MACD
- TAK 0.03
- CCI 0.22
- Stochastic Oscillator
- TAK 84.84
- CCI 41.01
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About CCI Crown Castle Inc.
Crown Castle International owns and leases roughly 40,000 cell towers in the United States. It also owns more than 90,000 route miles of fiber. It leases space on its towers to wireless service providers, which install equipment on the towers to support their wireless networks. The company's fiber is primarily leased by wireless service providers to set up small-cell network infrastructure and by enterprises for their internal connection needs. Crown Castle's towers and fiber are predominantly located in the largest us cities. The company has a very concentrated customer base, with about 75% of its revenue coming from the big three us mobile carriers. Crown Castle operates as a real estate investment trust.